UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000035351
Receipt number R000039068
Scientific Title On the relationship between the amount of physical activity during preoperative chemotherapy and the Muscle Loss Index in patients with esophageal cancer - Pilot study for multi - occupational collaborative intervention -
Date of disclosure of the study information 2020/01/04
Last modified on 2022/06/26 12:21:57

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

On the relationship between the amount of physical activity during preoperative chemotherapy and the Muscle Loss Index in patients with esophageal cancer - Pilot study for multi - occupational collaborative intervention -

Acronym

Study of esophageal cancer patients

Scientific Title

On the relationship between the amount of physical activity during preoperative chemotherapy and the Muscle Loss Index in patients with esophageal cancer - Pilot study for multi - occupational collaborative intervention -

Scientific Title:Acronym

Study of esophageal cancer patients

Region

Japan


Condition

Condition

Esophagus cancer

Classification by specialty

Surgery in general

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Verify the relationship between physical activity level and skeletal muscle atrophy of esophageal cancer patients during chemotherapy

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Skeletal muscle mass

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

65 years-old <=

Age-upper limit

100 years-old >

Gender

Male

Key inclusion criteria

1.aged at the time of obtaining 65 years or older 2.gender: male 3.stage: stage2-4 (esophageal cancer handling regulation 11th edition) 4.plan to implement DCF 2 courses as NAC 5.agree to participate in research by free will Can be obtained from the person himself / herself 6.I understand the clinical significance of this research and its importance

Key exclusion criteria

1.not having sarcopenia at recruitment based on criteria advocated by EWGSOP (European Working Group on Sarcopeneia in Older People) and Cut-off value of JSH (Japan Society of Hepatology) SARCOPENIA and diagnosis 3 1.SMI: 7.0 ( Less than 2 kg) 3. Grip strength: less than 26 (kg) 3. Walking speed: 0.8 (m / sec) or less 2) Effect on outcome such as cognitive dysfunction, cerebrovascular disorder, orthopedic disease, peripheral vascular disorder 3.It has electronic devices such as pacemakers whose measurement of Inbody is contraindicated 4.Has a gastrostomy due to eating difficulties


Target sample size

50


Research contact person

Name of lead principal investigator

1st name Tomohiro
Middle name
Last name Ikeda

Organization

OKAYAMA UNIVERSITY HOSPITAL

Division name

General rehabilitation department

Zip code

7008558

Address

700-8558,Okayamashi,kitaku,ksikatacho,2-5-1

TEL

0862357752

Email

lirfranjitte@yahoo.co.jp


Public contact

Name of contact person

1st name Tomohiro
Middle name
Last name Ikeda

Organization

OKAYAMA UNIVERSITY HOSPITAL

Division name

General rehabilitation department

Zip code

7008558

Address

700-8558,Okayamashi,kitaku,sikatacho,2-5-1

TEL

086-235-7752

Homepage URL


Email

lirfranjitte@yahoo.co.jp


Sponsor or person

Institute

OKAYAMA UNIVERSITY HOSPITAL

Institute

Department

Personal name



Funding Source

Organization

nothing

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

OKAYAMA UNIVERSITY HOSPITAL

Address

Okayamashi,kitaku,sikatacho,2-5-1

Tel

0862357752

Email

lirfranjitte@yahoo.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2020 Year 01 Month 04 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

10

Results


Results date posted


Results Delayed

Delay expected

Results Delay Reason

Due to the spread of COVID-19 infection

Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2018 Year 07 Month 04 Day

Date of IRB

2018 Year 11 Month 01 Day

Anticipated trial start date

2018 Year 11 Month 01 Day

Last follow-up date

2021 Year 02 Month 28 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded

2021 Year 03 Month 10 Day


Other

Other related information

nothing


Management information

Registered date

2018 Year 12 Month 23 Day

Last modified on

2022 Year 06 Month 26 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000039068


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name